Vildagliptin: optimal control in type 2 diabetes mellitus treatment
Incretin hormones are important for normal pancreatic islet function and glucose homeostasis. Sensitivity to glucose of the α- and β-cells of the pancreas is diminished in type 2 diabetes mellitus (T2DM), leading to impaired insulin secretion, insulin resistance due to elevated glucagon levels in hy...
Saved in:
Main Author: | Alexander Sergeevich Ametov |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/2ee27128d50d4f50b47926bff32edca5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011) -
The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
by: Juris J. Meier
Published: (2019) -
Incretins today: multiple effects and therapeutic potential
by: Oksana V. Tsygankova, et al.
Published: (2019) -
The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016) -
EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2013)